Trial Profile
A bioequivalence study of a trastuzumab biosimilar in healthy male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Sep 2020
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer; Gastric cancer
- Focus Pharmacokinetics
- 05 Nov 2012 New trial record